Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Gets Notice Of Allowance For Patent In The U.S.

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    09/03/2026 06:03
    March 9 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

RECEIVES NOTICE OF ALLOWANCE FOR MCT8 DEFICIENCY COMPOSITION PATENT IN THE U.S.

ANTICIPATES REGULATORY DECISION ON NDA APPLICATION IN SEPTEMBER 2026

EXPECTS RESULTING PATENT WILL BE ORANGE BOOK-LISTABLE, WITH AN ANTICIPATED EXPIRATION DATE OF 2045

Source text: ID:nMFN868SF5

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news